Envestnet Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,104
Closed -$14.2K 4180
2023
Q4
$14.2K Sell
1,104
-646
-37% -$15.1K ﹤0.01% 4027
2023
Q3
$64.7K Buy
1,750
+567
+48% +$25.2K ﹤0.01% 3917
2023
Q2
$47.6K Sell
1,183
-90
-7% -$5.09K ﹤0.01% 3874
2023
Q1
$92.3K Buy
1,273
+701
+123% +$68K ﹤0.01% 3805
2022
Q4
$46.9K Sell
572
-70
-11% -$7.29K ﹤0.01% 3873
2022
Q3
$61K Buy
642
+224
+54% +$25.2K ﹤0.01% 3795
2022
Q2
$81K Sell
418
-64
-13% -$10.4K ﹤0.01% 3777
2022
Q1
$112K Buy
+482
New +$153K ﹤0.01% 3787
2018
Q3
Sell
-79
Closed -$72K 1334
2018
Q2
$72K Buy
79
+11
+16% +$11.8K ﹤0.01% 2084
2018
Q1
$66K Buy
68
+28
+70% +$25.5K ﹤0.01% 2051
2017
Q4
$18K Sell
40
-18
-31% -$6.65K ﹤0.01% 2537
2017
Q3
$24K Buy
58
+3
+5% +$1.13K ﹤0.01% 2457
2017
Q2
$19K Sell
55
-1
-2% -$385 ﹤0.01% 2599
2017
Q1
$29K Buy
56
+4
+8% +$1.66K ﹤0.01% 2587
2016
Q4
$19K Buy
+52
New +$22K ﹤0.01% 2672

Other funds holding ATRA